Literature DB >> 32675870

BUILDING FOR INNOVATION IN MEDICAL CURRICULUM: FORM AND FUNCTION.

Robert D Simari1, Giulia Bonaminio1.   

Abstract

The University of Kansas School of Medicine (KUSOM) educates physicians to meet the needs of a rural and increasingly diverse state. In 2014, the school's curriculum was not aligned with student needs and faculty desires. Concurrently, the state teamed with philanthropic sources to fund the construction of a new health education building (HEB), resulting in a unique opportunity to simultaneously construct a building and a new curriculum. To support the needs of KUSOM students, the faculty developed the Active, Competency-based, Excellence-driven (ACE) curriculum. ACE focuses on multiple forms of active education including flipped classrooms, case-based collaborative and problem-based learning, and interprofessional and simulation-based activities. The HEB was designed to support ACE with large flat learning studios, small group rooms, and multiple simulation spaces. This unique opportunity to innovate the form and function of KUSOM medical education forever changed the future of medicine in Kansas and provided a paradigm for curricular change.
© 2020 The American Clinical and Climatological Association.

Year:  2020        PMID: 32675870      PMCID: PMC7358495     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  3 in total

1.  Calls for reform of medical education by the Carnegie Foundation for the Advancement of Teaching: 1910 and 2010.

Authors:  David M Irby; Molly Cooke; Bridget C O'Brien
Journal:  Acad Med       Date:  2010-02       Impact factor: 6.893

2.  A Continuum of Innovation: Curricular Renewal Strategies in Undergraduate Medical Education, 2010-2018.

Authors:  Daniel A Novak; Ronan Hallowell; Ron Ben-Ari; Donna Elliott
Journal:  Acad Med       Date:  2019-11       Impact factor: 6.893

3.  Assessing the Effectiveness of Case-Based Collaborative Learning via Randomized Controlled Trial.

Authors:  Edward Krupat; Jeremy B Richards; Amy M Sullivan; Thomas J Fleenor; Richard M Schwartzstein
Journal:  Acad Med       Date:  2016-05       Impact factor: 6.893

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.